"I Do Not Know About Clinical Effects... Will Meet With Victims of Stock Manipulation"

Kim Seungwon, nominee for Minister of Justice, denied allegations that he was involved in Genencell-related lobbying with the Ministry of Food and Drug Safety, stating that he merely conveyed information regarding procedural matters.

Kim Seungwon, nominee for Minister of Justice, is taking the oath at the confirmation hearing held by the National Assembly’s Legislation and Judiciary Committee on the 15th. Photo by Yonhap News

Kim Seungwon, nominee for Minister of Justice, is taking the oath at the confirmation hearing held by the National Assembly’s Legislation and Judiciary Committee on the 15th. Photo by Yonhap News

View original image

At the National Assembly confirmation hearing on the 15th, when Assemblyman Kwak Kyutaek of the People Power Party questioned him about the suspicions, Kim replied, "The exact message I conveyed to the head of the Ministry of Food and Drug Safety was to check and look into whether there were any procedural delays or unfairness." He further clarified that he was simply asking for confirmation of the delay.


He added, "I called only once, on October 12, 2021, and after that, I never spoke again with the head of the Ministry of Food and Drug Safety nor received any reports on the status of the clinical trials. I believe that merely conveying that petition fulfilled my role."


Kim is suspected of having forwarded a message, at the request of a broker surnamed Yang on October 12, 2021, to Kangrip Kim, who was the head of the Ministry of Food and Drug Safety at the time, asking for expedited approval of Genencell's COVID-19 treatment clinical trial.


Regarding Assemblywoman Kim Minjeon's point that the ruling on Genencell’s preclinical animal tests being “manipulated” was included in a court judgment, Kim reiterated, "The petition I delivered was only to ask for a review of unfair procedures," and added, "I do not know about the effects. The Ministry of Food and Drug Safety made the decision, and it was started based on the advisory committee’s conclusion that the clinical procedure was appropriate, as far as I know."


When asked about issues raised with the human clinical trials conducted in India and the claim that there was only partial efficacy in mild cases, Kim responded, "If I had known that, I wouldn’t be sitting here today. I would have been indicted, had a warrant issued for my arrest, or been in court."



Questions were also raised about responsibility for damages from alleged stock price manipulation. When asked by Assemblyman Kim if he bore responsibility, since the related stock price first soared and then collapsed, even if he was unaware, Kim replied, "If I become Minister, I will meet with the victims and strive to help restore their damages," and added, "I have always argued that those responsible for stock manipulation should be punished accordingly. I will meet with the victims."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing